Home › Research › Brain scans and imaging
The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
Macedo AC, Tissot C, Therriault J, Servaes S, Wang YT, Fernandez-Arias J, Rahmouni N, Lussier FZ et al.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023-06-15
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
The database search returned 262 results, and after assessment for eligibility, 21 studies were selected. Overall, most studies indicate that PET-based Braak staging may be an efficient method to stage AD since it presents an adequate ability to discriminate between phases of the AD continuum and correlates with clinical, fluid, and imaging biomarkers of AD. However, the translation of the original Braak descriptions to tau PET was done taking into account the limitations of this imaging technique. This led to important interstudy variability in the anatomic definitions of Braak stage regions of interest. Refinements in this staging system are necessary to incorporate atypical variants and Braak-nonconformant cases. Further studies are needed to understand the possible applications of PET-based Braak staging to clinical practice and research. Furthermore, there is a need for standardization in the topographic definitions of Braak stage regions of interest to guarantee reproducibility and methodologic homogeneity across studies.
What this study adds
Evidence grade: Low
This is a narrative review. This review of 21 studies suggests that tau PET-based Braak staging may help stage Alzheimer's disease and correlates with clinical and biomarker measures. However, definitions of brain regions varied between studies, so standardization is needed before it can be applied in practice.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Macedo, A. C., Tissot, C., Therriault, J., Servaes, S., Wang, Y. T., Fernandez-Arias, J., et al. (2023). The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.122.265200
Vancouver
Macedo AC, Tissot C, Therriault J, Servaes S, Wang YT, Fernandez-Arias J, et al. The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2023. doi:10.2967/jnumed.122.265200. PMID: 37321820.
BibTeX
@article{macedo2023-37321820,
author = {Macedo, A. C. and Tissot, C. and Therriault, J. and Servaes, S. and Wang, Y. T. and Fernandez-Arias, J. and Rahmouni, N. and Lussier, F. Z. and others},
title = {{The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework}},
journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
year = {2023},
doi = {10.2967/jnumed.122.265200},
pmid = {37321820},
url = {https://doi.org/10.2967/jnumed.122.265200}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The database search returned 262 results, and after assessment for eligibility, 21 studies were selected.
- Overall, most studies indicate that PET-based Braak staging may be an efficient method to stage AD since it presents an adequate ability to discriminate between phases of the AD continuum and correlates with clinical, fluid, and imaging biomarkers of AD.
- However, the translation of the original Braak descriptions to tau PET was done taking into account the limitations of this imaging technique.
- This led to important interstudy variability in the anatomic definitions of Braak stage regions of interest.
- Refinements in this staging system are necessary to incorporate atypical variants and Braak-nonconformant cases.
Why it matters
This review of 21 studies suggests that tau PET-based Braak staging may help stage Alzheimer's disease and correlates with clinical and biomarker measures. However, definitions of brain regions varied between studies, so standardization is needed before it can be applied in practice.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Evidence strengthLow
How this study scored 49/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of nuclear medicine : official publication, Society of Nuclear Medicine) |
| Journal's citation record | 2 / 4 | Journal of Nuclear Medicine: journal h-index 230 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 81 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 16.2 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 4 / 6 | Cited 14.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 9 other studies in this library |
| Still being cited | 3 / 4 | Cited 80 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Pedro Rosa‐Neto: h-index 89 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Pittsburgh: institution h-index 1,470 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 4 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37321820) |
| Free to read | 2 / 2 | Free to read |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.2967/jnumed.122.265200
- PubMed: 37321820
- Original source →
- Free full text: Journal of Nuclear Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 19.
Later studies that cite this one
9 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Brain scans and imaging from nearby years
Also tagged “phosphorylated”
733 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 733 tagged studies.